| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |